In our cohort, among the eight cases with IDH-wt astrocytoma, two were molecularly reclassified into GBM based on CGPT results, though they were originally categorized as anaplastic astrocytoma and Grade 3 IDH-wt in the WHO 2016 classification of CNS tumor. Here, IDH1 is linked to central nervous system neoplasm.